Overview

A Phase 1 Study Assessing Local Cutaneous Effects of SB204

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
In this study, color (erythema) and pH will be measured on 3 consecutive days after application of 2 doses of SB204 to the cheeks of healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Novan, Inc.